APA (7th ed.) Citation

Io, K., Nagai, K., Kakihara, B., Izumi, K., & Kitagawa, T. (2025). Efficacy and safety of the thiotepa–busulfan conditioning regimen as for autologous stem cell transplantation in relapsed/refractory systemic diffuse large B cell lymphoma. International Journal of Hematology, 121(6), 813-819. https://doi.org/10.1007/s12185-025-03946-w

Chicago Style (17th ed.) Citation

Io, Katsuhiro, Kenichi Nagai, Bunta Kakihara, Kiyotaka Izumi, and Tomoya Kitagawa. "Efficacy and Safety of the Thiotepa–busulfan Conditioning Regimen as for Autologous Stem Cell Transplantation in Relapsed/refractory Systemic Diffuse Large B Cell Lymphoma." International Journal of Hematology 121, no. 6 (2025): 813-819. https://doi.org/10.1007/s12185-025-03946-w.

MLA (9th ed.) Citation

Io, Katsuhiro, et al. "Efficacy and Safety of the Thiotepa–busulfan Conditioning Regimen as for Autologous Stem Cell Transplantation in Relapsed/refractory Systemic Diffuse Large B Cell Lymphoma." International Journal of Hematology, vol. 121, no. 6, 2025, pp. 813-819, https://doi.org/10.1007/s12185-025-03946-w.